Important information related to COVID-19: As the COVID-19 situation evolves, we are learning more about transmission and potential risks during endoscopic and diagnostic procedures. We believe that the joint GI society recommendations(see link) proposed for endoscopy should be applied to all motility studies. Our primary concern during this time of uncertainty should be to reduce exposure and conserve PPE. We appreciate the work that the societies have put forth and are in solidarity with our other gastroenterology and hepatology organizations.
Microbiota and the brain-gut connection
Written by Stefanie Twist
Reviewed by Dr. Premsyl Bercik
In the past few years, attention devoted to microbiota and the brain-gut connection has increased. Gut microbiota encompasses the bacterial colonies, fungi, viruses, and other microbes that live within our gastrointestinal tract.(1, 2) Importance of bacteria in our GI tract should not be understated as they contribute to key biological processes in our body. However, when there are changes to this balance, it can be the reason symptoms develop.
Microbiota development starts at birth. Factors such as vaginal versus cesarean birth and breastfeeding versus formula shape the diversity and proliferation of strains of bacteria.(2, 3) Human breastmilk has nutrients which can help shape the microbiome and immune development of children. Infant’s initial exposure to microbiota is through the act of birth. Cesarean section births correlated with increased risk of children developing celiac disease, asthma, type 1 diabetes, and obesity.(4) This may occur because infants born vaginally are exposed to their mother’s vaginal microbiota while those born via cesarean are not.
ANMS Mobile App
A Message from the ANMS President Beverley Greenwood-Van Meerveld, PhD
An update concerning our 2020 Clinical Course scheduled for August 7-9, 2020 in Philadelphia.
Most importantly, we know that everyone is affected by the COVID-19 pandemic and our hearts go out to all of our colleagues and friends who are on the front-line treating patients, and to those suffering personally, or helping others afflicted.
We will continue to work towards holding the meeting but at the same time we know that this pandemic has not peaked in the US. Although we have planned a wonderful program for the ANMS Clinical Course in 2020, the ANMS leadership will review the situation and we will make several announcements in the coming months as we work with the team in Philadelphia.
Please stay safe during these challenging times.
2020 ANMS Annual Meeting
Clinical Course: Providing the best clinical care for our patients
Date: August 7-9, 2020
Location: Loews Hotel, Philadelphia, Pennsylvania
View program here.
Further information (Early bird registration rate, Hotel reservations: Click here
POSTPONED: WILL POST ONCE DECISION MADE ON WHEN IN 2021 TO BE HELD.
FNM 2020 – 4th Meeting of the Federation of Neurogastroenterology and Motility and Postgraduate Course on Gastrointestinal Motility
Hosted by: Australasian of Neurogastroenterology and Motility Association, Inc
Date: March 25-28, 2020
Location: Adelaide, Australia
CANCELLED: XVIth Little Brain Big Brain meeting (LBBB)
Date: March 22-25, 2020
Location: Port Elliot YHA, South Australia
The Mission and Goals of the ANMS
The American Neurogastroenterology and Motility Society is an organization that was established in 1980 dedicated to the study of neurogastroenterology and gastrointestinal motility and functional GI disorders.
Mission of the ANMS
To be the multidisciplinary society leading the field of neurogastroenterology by fostering excellence in research, education, training, and patient care.
Neurogastroenterology encompasses the study of brain, gut, and their interactions with relevance to the understanding and management of GI motility and functional GI disorders.
Start receiving YOUR benefits today:
ANMS Grant Programs
ANMS is accepting applications for the Ironwood Irritable Bowel Syndrome (IBS) Innovation Research Award. One grant of up to $30,000 will be awarded to provide a one-year grant to support high-risk, cutting-edge clinical, translational and/or basic research in the field of IBS.
Applicants must be members of the ANMS at the time of application and also the mentors must be ANMS members. The application deadline is November 1, 2019. Funds will be available in February 2020. Click here for more information and to submit your on-line application.
Objective: To support high-risk, cutting edge, innovative and novel research to address existing gaps in knowledge related to all facets of IBS. Applications related to the broad range of topics relevant to this IBS are welcome by the ANMS. This grant is intended to support work that will generate preliminary data that will lead to extramurally-funded research grants and to promote career development in the area of neurogastroenterology and motility.
Description: The Ironwood IBS Innovation Research Award will provide support for Assistant, Associate and Full Professors pursuing extramurally funded research careers in the area of neurogastroenterology and motility. Grant applications should be used to make the applicant competitive for subsequent extramural research funding, such as NIH K01, K08, K23, K24, R21, and R01 grants and career development awards from major societies and foundations.
Eligibility: The eligibility will be limited to Assistant, Associate, or Full Professors with extramural funding no greater than $300,000 per year in direct costs. Applications from New Investigators (within 5 years of first full academic appointment and never having received independent federal funds) are given special consideration during peer review and at the time of funding consideration.
ANMS is accepting applications for the 2020 Small Grants Program. The Research Program will provide 2 grants of $30,000 each. The program will fund research projects focused on any topic area relevant to neurogastroenterology and motility. It is anticipated that one award will be made to a clinical/translational investigator and one award will be made to a basic science investigator. Applicants must have a primary appointment at an academic institution. Applicants must also be a member of the ANMS at the time of application and also the mentor must be an ANMS member. The application deadline is November 1, 2019. Funds will be available to successful applicants in February 2020. Click here for more information and to submit your on-line application.
Description: Will provide support for junior faculty, postdoctoral research fellows, and senior GI fellows pursuing extramurally funded research careers in the area of neurogastroenterology and GI motility. Two grants of up to $30,000 each will be awarded in 2020 for qualified applicants. It is anticipated that one award will be made to a basic science/translational investigator and that one award will be made to a clinical/translational investigator. Grant applications should be used to make the applicant competitive for subsequent extramural research funding, such as NIH K01, K08, K23, K24, R21, and R01 grants and career development awards from major societies and foundations.
Applications will be evaluated by members of the Research Committee.
The American Neurogastroenterology and Motility Society (ANMS) Research Committee is launching a Mentoring Program in Neurogastroenterology and Motility to help young clinicians and scientists (MDs, PhDs, or DVMs) as they start their research career in the areas of neurogastroenterology and gastrointestinal motility. The areas of interest can be varied and the research may take the form of clinical investigation, basic science research, or translational science research. The objective of the program is to provide guidance to individuals at an early stage of their career who may enter the field of neurogastroenterology and gastrointestinal motility.
Manuscripts Sponsored by ANMS on Clinical Topics in GI Motility
Training in gastrointestinal motility.
Dig Dis. 2006;24(3-4):221-7.
Murray JA, Clouse RE, Conklin JL.
Components of the standard esophageal manometry.
Neurogastroenterology and Motility 2003;15(6):591-606.
Gastroesophageal Reflux Disease.
N Engl J Med 2008;359:1700-7.